Meet HyTest Team at Medica 2019

Published: 10.10.2019
25 Sep, 2019
New Team Member - CCO Juhana Rauramo

We are delighted to introduce our latest team member, CCO Juhana Rauramo.

Read more
29 Aug, 2019
New Article: Troponin Complexes in the Blood of AMI Patients

Using several immunodiagnostic techniques, our researchers investigated in what forms cTnI and cTnT (as components of the troponin complexes) are present in the blood of patients with acute myocardial infarction.

Read more
29 Aug, 2019
New Article: Neprilysin-Derived BNP Fragments and Possible Options for Targeted Therapy in Heart Failure

The article describes the development of a novel immunoassay for the quantification of BNP fragments cleaved by neprilysin.

Read more
03 Jul, 2019
NEW product! Beta-amyloid 1-42 antibodies

Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia. We provide three in vitro produced monoclonal antibodies that are specific to human beta-amyloid 1-42.

Read more
02 Jul, 2019
Meet us at AACC 2019 in Anaheim and Register to Workshop
We will be attending the 2019 AACC Annual Meeting & Clinical Lab Expo. The exhibition will be on August  6 - 8 in Anaheim.
Read more
29 May, 2019
HyTest Posters at EuroMedLab 2019 Conference

23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - EuroMedLab 2019 was held in Barcelona, May 2019.

Read more
28 May, 2019
Winner of the Second EFLM-HyTest Cardiac Marker Award

During our 25th anniversary year in collaboration with EFLM through the sponsorship of their award, we have had an excellent opportunity to show our appreciation towards scientific work in the field of cardiovascular diseases. Read more about our anniversary year campaign Challenge25 here.

Read more
29 Apr, 2019
New! Anti-Müllerian Hormone Antibodies

Anti-Müllerian hormone (AMH) is a dimeric glycoprotein that is produced by granulosa cells in females and it is currently considered to be the most reliable biomarker for the assessment of ovarian reserve in women.

Read more
27 Mar, 2019
Recorded Talk by Prof. David Eckersall: Canine CRP and Other Acute Phase Proteins as Markers of Inflammation
We invited Prof. David Eckersall to give a talk in VMX 2019 about the usefulness of canine CRP and other acute phase proteins in veterinary diagnostics.
Read more
25 Mar, 2019
Cardiac Marker Dialogues Meeting Sponsorship
We are delighted to let you know that we are sponsoring the 4th Cardiac Marker Dialogues meeting in April.
Read more
27 Feb, 2019
Come to Meet our Team at CACLP, China
We will attend the 16th China Association of Clinical Laboratory Practice Expo held at Nanchang Greenland International Expo Center, on 22-24 March.
Read more
18 Dec, 2018
Season's Greetings
We would like to wish you immense happiness during this holiday season and throughout the coming year.
Read more
29 Nov, 2018
New MAbs Specific to Canine Parvovirus (CPV)
We have included three new anti-CPV antibodies to our offering. These new MAbs work well in different pair combinations demonstrating high sensitivity in sandwich immunoassays.
Read more
27 Nov, 2018
Come to Meet our Team at VMX 2019
We will be present at the VMX: Veterinary Meeting & Expo, Orlando during January 19-23.
Read more
31 Oct, 2018
NEW! Recombinant Feline SAA Protein
Serum amyloid A is used as an inflammatory marker in different animals. In cats, it is the only biomarker that shows a rapid and significant response to inflammation.
Read more
30 Oct, 2018
Call for Nominations - Sponsoring EFLM Award
We are delighted to let you know that we are sponsoring the EFLM-HyTest Cardiac Marker Award for remarkable scientific work in the field of cardiovascular diseases.
Read more
22 Oct, 2018
Meet us at Medica Exhibition in November
If you or your colleagues will attend the MEDICA 2018 - the World's Leading Medical Forum - from November 12 to 15, in Düsseldorf, Germany, please schedule a meeting with us.
Read more
25 Sep, 2018
HyTest Supports Cancer Research
HyTest supports cancer research and families burdened with the disease
Read more
06 Sep, 2018
Summa Equity Acquires Finnish Antibody Manufacturer HyTest
Summa Equity will become majority shareholder of the Finnish company HyTest, producer of antibodies and antigens for the diagnostic industry.
Read more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!